SSRIs Linked to Reduced Relative Risk for Mortality in COVID-19
Relative risks for mortality significantly reduced for any SSRI, fluoxetine, and fluoxetine or fluvoxamine
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.